British Association for the Study of the Liver. Annual Meeting 4-6 September 2013 QEII Conference Centre, London
|
|
- Randall Cole
- 6 years ago
- Views:
Transcription
1 British Association for the Study of the Liver Annual Meeting 4-6 September 2013 QEII Conference Centre, London DAY ONE WEDNESDAY 4 SEPTEMBER Early registration for Women in Hepatology meeting 9:00 10:00 Women in Hepatology meeting (Westminster Suite) 9:30-10:30 Registration and Coffee 10: HCC SYMPOSIUM Chair: Dr Phil Harrison PART I - Is it all about to change? 10:30-10:50 Molecular classification of HCC Dr Augusto Villanueva, Kings College London 10:50-11:10 Activation of signalling pathways in HCC Dr Helen Reeves, Northern Institute for Cancer Research 11:10-11:30 Prospects of therapeutic vaccination against cancer and chronic infections Prof Farzin Farzaneh, Kings College London 11:30-11:50 Integration of new drugs into the treatment pathway Prof Daniel Palmer, University of Liverpool 11:50-12:00 Discussion 12:00-12:24 PART II - HCC Free Papers A1 A2 The interaction of human hepatocellular carcinoma with dendritic cells is able to induce a novel subset of CD8+ regulatory T-cells Ka-Kit Li et al, Centre for Liver Research and NIHR Biomedical Research Unit, University of Birmingham, Birmingham, UK ImageStream Circulating Tumour Cell (CTC) detection in hepatocellular cancer (HCC) preliminary pre clinical and clinical data Laura Ogle et al, Northern Institute for Cancer Research, Newcastle University 12:30-13:30 Lunch and Satellite Symposium 1 MSD (Mountbatten Room) 13:45-17:14 VIRAL SYMPOSIUM Chair: Prof Graham Foster
2 DAY ONE (Viral Symposium) ctd... PART I - HCV - Are we there yet? 13:45-14:05 Protease inhibitors, today and tomorrow - supporters for IFN? Prof Geoff Dusheiko, Royal Free London NHS Foundation Trust 14:05-14:20 NS5A inhibitors and cyclophilins - what will they bring? Prof Matthew Cramp, Plymouth Hospitals NHS Trust 14:20-14:35 NS5B inhibitors Dr Dan Forton, St George's Healthcare NHS Trust 14:35-15:05 Bringing it all together: IFN free therapy for all what combinations will work and for who? Prof Nezam Afdhal, Beth Israel Deaconess Liver Centre 15:05-15:20 Discussion - When will these drugs be available? 15:20-15:50 Coffee PART II - Eradicating the virus - from the host and from society 15:50-16:05 Treat and clear the planet Dr Natasha Martin, University of Bristol 16:05-16:20 HCV in the cell - how does it avoid IFN? Prof John McLauchlan, University of Glasgow 16:20-16:35 Travelling around - cell to cell transfer of HCV Prof Jane McKeating, University of Birmingham 16:35-16:50 A vaccine coming soon or coming too late? Dr Ellie Barnes, Nuffield Dept of Medicine, University of Oxford 16:50-17:14 PART III - Viral Free Papers A3 A4 Does previous Hepatitis B infection influence liver-related outcomes in patients with chronic hepatitis C Elizabeth Thomas et al, University of Glasgow Hepatitis C patients incur significantly greater healthcare costs, with or without cirrhosis - a nationwide analysis of hospital episode statistics Richard J Aspinall et al, Portsmouth Hospitals NHS Trust, Queen Alexandra Hospital, Portsmouth, UK 17:30-18:30 Satellite Symposium 2 Janssen (Westminster Suite) 19:00-22:00 President's Dinner (by invitation) Cinnamon Club
3 DAY TWO THURSDAY 5 SEPTEMBER 7:15-9:00 Registration & Coffee 8:00-9:00 Satellite Symposium 3 Gilead (Mountbatten Room) 9:10-11:00 FIBROSIS SYMPOSIUM Chair: Dr Ashley Brown 9:10-9:30 Fibrosis: challenges for the pathologist Dr Judy Wyatt, The Leeds Teaching Hospitals NHS Trust 9:30-9:50 Antifibrotic therapy: translation of basic science into clinical practice Dr Jonathan Fallowfield, University of Edinburgh 9:50-10:10 Selective targeting of fibrogenic NF-kappaB signalling in liver fibrosis therapy Dr Fiona Oakley, The Leeds Hospital NHS Trust 10:10-10:30 Coagulation and fibrosis Prof Mark Thursz, Imperial College 10:30-11:00 Ralph Wright Lecture Fibrosis and repair Prof Stuart Forbes, University of Edinburgh 11:00-11:30 Coffee 11:30-12:00 Sheila Sherlock Prize Lecture Chair: Prof Graham Foster The role of CLEVER-1 in lymphocyte recruitment- a potential therapeutic target in inflammatory liver disease Dr Shishir Shetty MRCP PhD, Wellcome Intermediate Clinical Fellow, University of Birmingham 12:00-13:00 FREE PAPERS Chair: Dr Mark Hudson A5 A6 A7 A8 Award Presentation by Professor Roger Williams Winner of the Foundation for Liver Research Award for Basic Science : Identification and characterization of a novel cancer cell survival effector in hepatocellular carcinoma Salvatore Papa et al, Cell Signalling and Cancer Laboratory, Institute of Hepatology London, Foundation for Liver Research, UK Everolimus-based immunosuppression provides superior renal function and comparable efficacy versus standard tacrolimus in de novo liver transplant recipients: 24-month results of a randomised controlled trial A MacGilchrist et al, Royal Infirmary of Edinburgh, Edinburgh, Scotland Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease Stuart McPherson et al, Freeman Hospital, Newcastle upon Tyne, UK Sustained restoration of innate immune responses and sag decline in sequential NUC therapy following failed Pegylated-Interferon therapy in Chronic Hepatitis B Upkar S. Gill et al, Hepatology Unit, Centre for Digestive Diseases, Blizard Institute, Barts and The London SMD, QMUL, London, United Kingdom
4 DAY TWO (Free Papers) ctd... A9 Osteopontin enhances liver progenitor response during progressive nonalcoholic steatohepatitis Jason Coombes et al, The Institute of Hepatology, Foundation for Liver Research, London 13:00-14:00 Lunch and Directed Poster Viewing 14:00-16:00 TRANSPLANTATION SYMPOSIUM Co-chairs: Prof Derek Manas and Prof John O'Grady 14:00-14:30 Williams-Calne Lecture Liver Failure and Liver Transplantation for "Non Alcoholic Steatohepatitis" Prof M. Charlton, USA 14:30-14:45 How best to assess the high-risk recipient Dr Will Bernal, King s College Hospital NHS Foundation Trust 14:45-15:05 The day I reached my limit Dr Mark Hudson, The Newcastle Upon Tyne Hospitals NHS Foundation Trust Mr John Isaac, University Hospitals Birmingham NHS Foundation Trust 15:05-15:35 HCV: Managing post transplant drug interactions in 2013 Dr Audrey Coilly, Paris 15:35-16:00 Debate: The house believes that too much resource has been allocated to transplanting recipients with HCC For: Prof John O'Grady / Against: Dr Alex Gimson 16:00-16:30 Coffee 16:30-17:30 END OF LIFE SYMPOSIUM Chair: Amanda Clements 16:30-16:40 Case Study Amanda Clements, Plymouth Hospitals NHS Trust 16:40-17:10 Getting it right: improving end of life care for people with liver disease Dr Stuart Kendrick, Institute of Cellular Medicine, Newcsatle-upon-Tyne 17:10-17:30 Innovative approaches in caring for patients with end stage liver disease Mark Holmes, Nottingham University Hospitals NHS Trust 17:30-18:00 A SUMMARY OF NATIONAL STUDIES Prof Will Irving, University of Nottingham; Prof Graham Foster, QMUL 18:00-19:00 Directed Poster Viewing Refreshments will be served 19:30-23:00 Annual Dinner
5 DAY THREE FRIDAY 6 SEPTEMBER 7:15 9:00 Registration & Coffee 8:00-9:00 Satellite Symposium 4 Norgine (Westminster Suite) 9:10-10:34 PART I - FREE PAPERS Co-Chair: Profs Matthew Cramp & Geoff Dusheiko A10 A11 A12 A13 A14 A15 A16 Non-invasive biomarkers unearth undiagnosed cirrhosis in the community David J Harman et al, NIHR Nottingham Digestive Diseases Biomedical Research Unit A novel multi-genotypic naturally infectious system to study hepatitis C virus (HCV) infection in vitro Antonio Riva et al, The Institute of Hepatology, Foundation for Liver Research Functional, anthropometric and prognostic associations of muscle wasting assessed by Computed-Tomography in patients with cirrhosis Ziva Mrevlje et al, Institute of Liver Studies, Kings College Hospital Gene expression analysis of recipient NK cells after Liver Transplantation demonstrates downregulation of STAT4 Khaleel M Jamil et al, Imperial College London Collagen proportionate area but not Ishak fibrosis stage on liver biopsy correlates with age in Chronic Hepatitis B infected young adults Upkar S. Gill et al, Hepatology Unit, Centre for Digestive Diseases, Blizard Institute, Barts and The London SMD, QMUL, London, United Kingdom Generation of hepatocytes from Arthrogryposis-Renal dysfunction- Cholestasis (ARC) syndrome patient-derived induced Pluripotent Stem Cells Maëlle Lorvellec et al, School of Immunity & Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK Expression of interferon-stimulated genes (IGS) in the liver role for predicting response to antiviral therapy in chronic hepatitis B infection? Ivana Carey et al, King's College Hospital NHS Foundation Trust Award to winning poster presentation 10:35-11:00 Coffee 11:00-12:00 PART II - An Update on Autoimmune Liver Disorders Chair: Dr Graeme Alexander 11:00-11:20 PBC Prof David Jones, University of Newcastle 11:20-11:40 PSC Dr Roger Chapman,Oxford University Hospitals NHS Trust
6 DAY THREE ctd... 11:40-12:00 Autoimmune Hepatitis Prof Ansgar Lohse, University Hamburg 12:00-12:50 Annual Business Meeting and Review (Members Only) 13:00-14:00 Lunch and Satellite Symposium 5 BMS (Westminster Suite) 14:10-16:00 ALCOHOL SYMPOSIUM Co-Chairs: Dr Bill Griffiths, Dr Nick Sheron Also joined by Dr Michael Glynn, Barts Health NHS Trust & National Clinical Director for GI and Liver Diseases at the National Commissioning Board 14:00-14:30 BLT Lecture Health First: A comprehensive approach to addressing alcohol harm Prof Linda Bauld, University of Stirling 14:30-15:00 Measuring the Units: A review of patients who died with alcohol-related liver disease Dr Neil Smith, Deputy Chief Executive, NCEPOD 15:00-15:20 Alcohol care teams and collaborative liver and psychiatry care Dr Kieran Moriarty, Bolton NHS Trust 15:20-15:40 Moving the national alcohol agenda forwards Dr Nick Sheron, Southampton University 15:40-16:00 Open forum debate
7 SPONSOR LIST Satellite Sponsors Bristol-Myers Squibb Pharmaceuticals Ltd Gilead Janssen Merck Sharp & Dohme Ltd Norgine Pharmaceuticals Ltd Major Sponsors Janssen Therapeutics Key Sponsors Boehringer-Ingelheim Ltd Sponsors AbbVie Roche Products Ltd Associate Sponsors Astellas Pharma UK Ltd Echosens Lundbeck Ltd Sequana Medical AG Exhibitors British Liver Trust Children s Liver Disease Foundation
BASL Annual Meeting Programme BASIC SCIENCE SYMPOSIUM UNDERSTANDING AND HARNESSING VIRAL RESISTANCE Chairs: Matthew Cramp
BASL Annual Meeting Programme BASIC SCIENCE SYMPOSIUM UNDERSTANDING AND HARNESSING VIRAL RESISTANCE Chairs: Matthew Cramp WEDNESDAY 19 th September 2018 09:30 09:55 09:55 10:20 10:20 10:45 The HBV and
More informationMembership of cirrhosis guideline Committee
Membership of cirrhosis guideline Committee The Committee will operate as an advisory Committee to NICE s Board, developing a guideline on cirrhosis. The terms of reference and standing orders for the
More informationRESEARCH IN CARDIOLOGY Why, When, Where and How?
RESEARCH IN CARDIOLOGY Why, When, Where and How? Friday 27th April 2012 Royal College of Physicians, London A comprehensive one day symposium for all trainees considering a period of research towards attaining
More informationTotal Payment for sponsored attendances by Healthcare Professionals: 182,677 ( 153,923 in 2013)
Gilead Sciences Ltd. 280 High Holborn London WC1V 7EE 31st March 2015 Relationships with Healthcare Professionals in the United Kingdom Gilead Sciences makes payments to Healthcare Professionals for consultancy
More informationESSO Advanced Course on Primary Liver Tumours
ESSO Advanced Course on Primary Liver Tumours 24-25 April 2014 LIVERPOOL (UK) Endorsed by ESSO Advanced Course on Primary Liver Tumours Chair Hassan Malik, University Hospital Aintree NHS Trust, Liverpool,
More informationProgramme. Scottish Psychiatry - setting the scene, addiction and transplant psychiatry Chaired by Dr Bruce Ritson OBE. MD. FRCPsych. FRCPE.
The Royal College of Psychiatrists in Scotland 20 th Anniversary of the Office in Scotland Thursday 2 nd and Friday 3 rd October 2014 George Hotel, Edinburgh, EH2 2PB Programme THURSDAY 2 nd OCTOBER 2014
More informationTreatment as prevention in HCV: Modelling impact among people who inject drugs and HIV+ men who have sex with men
Treatment as prevention in HCV: Modelling impact among people who inject drugs and HIV+ men who have sex with men Natasha Mar)n, Peter Vickerman, Ma/ Hickman School of Social and Community Medicine, University
More informationIdle thoughts of an idle fellow Professor Sir Simon Wessely, President of the Royal College of Psychiatrists
Royal College of Psychiatrists Faculty of Liaison Psychiatry Annual Residential Conference MUS at Transition International Perspectives 10-12 May 2017 Royal College of Psychiatrists Preliminary Programme
More informationORGANISING COMMITTEE
ORGANISING COMMITTEE Dr Anthony Maxwell (Chair) Dr Sarah Vinnicombe (Vice Chair) Dr Sheetal Sharma (Meetings Secretary) Dr Nisha Sharma (Secretary) Dr Julie Cox (Treasurer) Professor Iain Lyburn (Research)
More informationHEPATITIS B: WHO AND WHEN TO TREAT?
HEPATITIS B: WHO AND WHEN TO TREAT? George V. Papatheodoridis Professor in Medicine & Gastroenterology Medical School of National & Kapodistrian University of Athens Director of Academic Department of
More informationFibrosis stage reference images
Fibrosis stage reference images The following images are provided with the aim of improving inter-observer agreement in the assessment of fibrosis stage in liver biopsies, especially among non-specialist
More informationIn Clinical Practice
In Clinical Practice Taking a practical approach to clinical medicine, this series of smaller reference books is designed for the trainee physician, primary care physician, nurse practitioner and other
More information21 st Century Slide Based Pathology & Molecular Diagnostics: From the Laboratory to the Patient
A meeting hosted by at The Tower Hotel Conference Centre St Katharine's Way, London E1W 1LD 21 st Century Slide Based Pathology & Molecular Diagnostics: From the Laboratory to the Patient For Registration
More informationProfessor Caroline Sabin
Professor Caroline Sabin in partnership with Royal Free & University College Medical School London, UK COMPETING INTEREST OF FINANCIAL VALUE > 1,000 Statement Over the past five years, Caroline Sabin has
More informationFunding research for the future
Funding research for the future Dr Helen Compton (helen.compton@nihr.ac.uk) Stakeholder Engagement Manager NIHR, Central Commissioning Facility The future of health and social care depends on today's research
More informationProgramme - BSG Conference 2017
Programme - BSG Conference 2017 0800 Registration Wednesday 1 March 2017 0900 Welcome Adam Dangoor 0905 Update since BSG 2016 Board members, projects, follow-up Craig Gerrand NF1 Session 0915-1010 Chairs
More informationAnnual Academic Meeting (Incorporating the Annual Blair Bell Research Society Competition) Joint RCOG/Blair Bell Research Society
Annual Academic Meeting (Incorporating the Annual Blair Bell Research Society Competition) Joint RCOG/Blair Bell Research Society Thursday 17 Friday 18 January 2019 Location: RCOG Overview The Annual Academic
More informationNIHR Supporting collaboration in life sciences research
NIHR Supporting collaboration in life sciences research Dr Matt Hallsworth - Head of External Relations, NIHR Office for Clinical Research Infrastructure (NOCRI) Research funders build capabilities and
More informationBASCD Presidential Scientific Meeting Spring 2012
The British Association for the Study of Community Dentistry BASCD Presidential Scientific Meeting Spring 2012 Building Healthy Alliances... in Brave New Worlds Wednesday 18th and Thursday 19th April 2012
More informationSHARP ANNUAL SCIENTIFIC MEETING
HILTON DUNKELD HOUSE HOTEL 19 th /20 th NOVEMBER Organising Committee Professor Tom MacDonald Dr Alan Begg Secretariat Miss Victoria Kirkwood THURSDAY 19 th NOVEMBER PROGRAMME 08.15 Registration Opens
More informationPublic Health Wales Phase 1 Implementation Programme Report Appendix 2 APPENDIX 2 EXPERT ADVISORY GROUPS MEMBERSHIP
Public Health Phase 1 Implementation Programme Report Appendix 2 A2 APPENDIX 2: MEMBERSHIP APPENDIX 2 EXPERT ADVISORY GROUPS MEMBERSHIP Date: 13 Feb 2015 Version: 1 Page: 1 of 9 A2.1 Physical Activity
More informationINTERNATIONAL WORKSHOP ON MANAGEMENT OF END STAGE LIVER DISEASE DUE TO NASH WASHINGTON DC, USA 6-7 OCTOBER 2016 MEETING PROSPECTUS www.expertmedicalevents.com www.expertmedicalevents.com INTRODUCTION NAFLD
More informationInaugural UK IgG4-related disease Symposium. Royal College of Physicians, London
Inaugural UK IgG4-related disease Symposium Friday 23 rd March 2018 Royal College of Physicians, London CPD points (applied for) Introduction We are delighted to invite you to the inaugural UK IgG4-Related
More informationMS MasterClass Specialist Neurologists (MS4.1) Module 1 14,15 & 16 March Halifax Hall, Sheffield
14,15 & 16 March 2018 - Halifax Hall, Sheffield Day 1-14 March 2018 10:15 Registration and refreshments 10:30 Introductions, pre-course analysis and course structure 11:30 Getting the diagnosis right and
More informationLYON. FRANCE NOVEMBER / 2013 TRANSLATIONAL RESEARCH IN CHRONIC VIRAL HEPATITIS - BRIDGING BASIC SCIENCE AND CLINICAL RESEARCH
LYON. FRANCE NOVEMBER 29-30 / 2013 TRANSLATIONAL RESEARCH IN CHRONIC VIRAL HEPATITIS - BRIDGING BASIC SCIENCE https://events.easl.eu/eventportal/ Information/MLYON2013/HOME.aspx Abstract submission deadline:
More informationHCV elimination : lessons from Scotland
HCV elimination : lessons from Scotland Sharon Hutchinson Glasgow Caledonian University / Health Protection Scotland BHIVA Hepatology Highlights, Edinburgh, 17 th April 2018 Disclosures Honoraria from
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal Review of TA96; Adefovir dipivoxil and peginterferon alfa-2a for
More informationConsensus AASLD-EASL HBV Treatment Endpoint and HBV Cure Definition
Consensus AASLD-EASL HBV Treatment Endpoint and HBV Cure Definition Anna S. Lok, MD, DSc Alice Lohrman Andrews Professor in Hepatology Director of Clinical Hepatology Assistant Dean for Clinical Research
More informationFriday 2nd and 3rd March 2018
REGISTER NOW! fungalupdate.org 13th Annual Fungal Update Meeting The Great Hall and Haberdashers Hall, St Bart's, London CPD Accreditation: Royal College of Pathologists - 11 credits Friday 2nd and 3rd
More informationHorizon Scanning Centre November Faldaprevir with BI for chronic hepatitis C infection, genotype 1 SUMMARY NIHR HSC ID: 7688
Horizon Scanning Centre November 2012 Faldaprevir with BI 207127 for chronic hepatitis C infection, genotype 1 SUMMARY NIHR HSC ID: 7688 This briefing is based on information available at the time of research
More informationBDHP Chronic Disease Theme Forum
BDHP Chronic Disease Theme Forum Friday 15 June 2018 Translational Research Institute (TRI), Woolloongabba, Brisbane, Queensland REGISTER TO ATTEND THIS FREE EVENT Metro South Hospital and Health Service
More informationORGANISING COMMITTEE
ORGANISING COMMITTEE Dr Anthony Maxwell (Chair) Dr Sarah Vinnicombe (Vice Chair) Dr Sheetal Sharma (Meetings Secretary) Dr Nisha Sharma (Secretary) Dr Julie Cox (Treasurer) Professor Iain Lyburn (Research)
More information3 Workshop on HCV THERAPY ADVANCES New Antivirals in Clinical Practice
3 Workshop on HCV THERAPY ADVANCES New Antivirals in Clinical Practice Rome, 13 December 2013 Management and monitoring of HCC in the future era of DAA s Prof. Massimo Colombo Chairman Department of Liver,
More informationHepatitis B Virus therapy. Maria Buti Hospital Universitario Valle Hebron Barcelona Spain
Hepatitis B Virus therapy Maria Buti Hospital Universitario Valle Hebron Barcelona Spain Disclosures Advisor: AbbVie, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck Sharp &
More informationWednesday 27 June Talks in Stripe Auditorium Catering breaks, exhibition and poster viewing in Stripe Lecture Room, Stripe Studio 1 and 2
Bone Research Society Annual Meeting The University of Winchester, Winchester, UK 27-29 June 2018 Preliminary programme Wednesday 27 June 1200 Foyer, The Stripe Building Registration desk opens, coffee
More informationPROGRAMME AT A GLANCE
PROGRAMME AT A GLANCE Hotel Hyatt Andaz Hotel Pullman Date Hall-H1 Hall-H2 Hall-P1 Hall-P2 Hall-P3 Hall-P4 Hall-P5 Hall-P6 Basic science workshop 1 Basic Science Workshop 2 Postgraduate Course - Liver
More informationThe Changing Population: Oral health needs and challenges in the next generation
BASCD Presidential Scientific Meeting Spring 2013 The Changing Population: Oral health needs and challenges in the next generation 18th and 19th April 2013 Palace Hotel, Buxton Introduction The spring
More informationAre Immune Modulators Really Needed to Cure HBV infection?
Are Immune Modulators Really Needed to Cure HBV infection? Harry L.A. Janssen Francis Family Chair of Hepatology Director Toronto Centre for Liver Disease University Health Network University of Toronto,
More informationIncorporating Joint Study Day with British Association of Paediatric Surgeons. The Oxford Belfry Hotel, Thame, Oxfordshire.
BSPGHAN Annual Meeting 23 rd 25 th January 2019 Incorporating Joint Study Day with British Association of Paediatric Surgeons The Belfry Hotel, Thame, shire Local Organisers: Dr Astor Rodrigues & Dr Lucy
More informationProgramme and Booking Details
Realising the Potential of Digital Mental Healthcare MindTech 2016 Mental Health Technology Symposium The NIHR MindTech Healthcare Technology Co-operative for Mental Health Programme and Booking Details
More informationNHS BLOOD AND TRANSPLANT ORGAN DONATION AND TRANSPLANTATION DIRECTORATE (ODT)
NHS BLOOD AND TRANSPLANT ORGAN DONATION AND TRANSPLANTATION DIRECTORATE (ODT) MINUTES OF THE SEVENTH MEETING OF THE LIVER PATIENT GROUPS AND ODT HELD ON WEDNESDAY, 13TH JULY 2016 AT FRIENDS HOUSE, 173-177
More informationNational Horizon Scanning Centre. Enhanced Liver Fibrosis Test (ELF) for evaluating liver fibrosis. June 2008
Enhanced Liver Fibrosis Test (ELF) for evaluating liver fibrosis June 2008 This technology summary is based on information available at the time of research and a limited literature search. It is not intended
More informationNHIVNA Pre-conference Study Day Current Issues in HIV, Hepatitis and other Blood-borne Viruses In collaboration with BASLNF
NHIVNA Pre-conference Study Day Current Issues in HIV, Hepatitis and other Blood-borne Viruses In collaboration with BASLNF Royal Armouries International, Leeds 17 June 2015 17 th Annual Conference of
More information2016 CRUK Lung Cancer Centre of Excellence Student/Postdoc Winter Workshop Programme
2016 CRUK Lung Cancer Centre of Excellence Student/Postdoc Winter Workshop Programme Thursday 1 st December 2016 09.15am 10.00am Registration and Refreshments 10.15am 10.30am Welcome 10.30am 11.15am Opening
More informationTrauma symposium 2016: Current and future treatment strategies
A MEETING ORGANISED BY THE ORTHOPAEDICS SECTION Trauma symposium 2016: Tuesday 23 Thursday 25 February 2016 CPD: 18 credits (6 per day) www.rsm.ac.uk/events/org06 Tel: 020 7290 3918 Email: orthopaedics@rsm.ac.uk
More informationEncompassing the Annual Commissioner (5-6) & Annual Provider (6-7) Finance Conferences
Bringing commissioners and providers together 5-7 July 2017, Novotel London West Encompassing the Annual Commissioner (5-6) & Annual Provider (6-7) Finance Conferences Wednesday 5 July 10:30 Registration,
More informationIntron A Hepatitis B. Intron A (interferon alfa-2b) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.01.01 Subject: Intron A Hepatitis B Page: 1 of 7 Last Review Date: November 30, 2018 Intron A Hepatitis
More informationAdvancing Health Systems for All in the SDG Era October 2018
Advancing Health Systems for All in the SDG Era 8 12 October 2018 Kabir Sheikh, Chair of Health Systems Global Health systems research is a field that takes on some of the defining concerns of our age
More informationFaculty of Pathology 37th Annual Symposium & Annual General Meeting. Thursday 7 th & Friday 8 th February 2019 Approved for up 8 CPD credits
Faculty of Pathology 37th Annual Symposium & Annual General Meeting Thursday 7 th & Friday 8 th February 2019 Approved for up 8 CPD credits Thursday 7th February 2019 (5 CPD) 9.30-10:00 Registration /
More informationFaculty of Pathology 37th Annual Symposium & Annual General Meeting. Thursday 7 th & Friday 8 th February 2019 Approved for up to 8 CPD credits
Faculty of Pathology 37th Annual Symposium & Annual General Meeting Thursday 7 th & Friday 8 th February 2019 Approved for up to 8 CPD credits Thursday 7th February 2019 (5 CPD) 9.30-10:00 Registration
More informationThe Changing World of Hepatitis C
The Changing World of Hepatitis C Alnoor Ramji Gastroenterology & Hepatology Clinical Associate Professor Division of Gastroenterology University Of British Columbia St. Paul s Hospital Site Disclosures
More information2018 UnitedHealthcare Services, Inc.
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2018 P 1127-9 Program Prior Authorization/Notification Medication Sovaldi (sofosbuvir) P&T Approval Date 2/2014, 4/2014, 5/2014, 8/2014,
More informationCHRONIC HEPATITIS B VIRUS Prospects for Cure
VIRAL HEPATITIS and CO-INFECTION with HIV Bucharest, Romania, 6-7 October, 2016 CHRONIC HEPATITIS B VIRUS Prospects for Cure Patrick T. F. Kennedy Reader in Hepatology & Consultant Hepatologist Blizard
More informationMEETING PROSPECTUS. International Workshop on NASH Biomarkers
International Workshop on NASH Biomarkers 2018 18-19 May 2018 Washington, D.C., USA MEETING PROSPECTUS www.expertmedicaleducation.com www.expertmedicalevents.com ADVANCING HEALTH GLOBALLY THROUGH INNOVATIVE
More informationSCOTTISH ONCOLOGY SUMMIT Double Tree by Hilton, Dunblane Hydro, Dunblane 1 st - 2 nd September 2017
Friday 1 st September 1300h 1400h Lunch (arrival, registration at conference foyer, coffee and sponsors exhibition) 1400h 1420h Prof Robert Jones Welcome/Announcements 1430h 1600h Parallel sessions: Lung
More informationDraft Programme Thursday 6 th Friday 7 th September
Draft Programme Thursday 6 th Friday 7 th September Thursday 6th September 08.30 09.45 Registration and Coffee Main Foyer 09.45 10.15 Welcome address Dr Simon Williams, ASO Chair & Professor David Burn,
More informationSuccessful hepatitis C treatment lowers risk of death for people with HIV and HCV co infection
Successful hepatitis C treatment lowers risk of death for people with HIV and HCV co infection Liz Highleyman Produced in collaboration with hivandhepatitis.com Published: 28 October 2015 Jump to Trends
More informationNational Haemoglobinopathy Registry. Annual Report 2017/18
National Haemoglobinopathy Registry Annual Report 2017/18 National Haemoglobinopathy Registry Annual Report (2017/18) Compiled by Mark Foster MDSAS 3 1 Introduction CHAPTER 1 The 2017/18 Annual Report
More informationLiver Pathology and the Clinician in 2015: At the Crossroads. Thomas D. Schiano, M.D. Mount Sinai Medical Center New York, New York
Liver Pathology and the Clinician in 2015: At the Crossroads Thomas D. Schiano, M.D. Mount Sinai Medical Center New York, New York DISCLOSURES Consultant for: Salix Merck Gilead BMS Synageva Research funding:
More informationNational Haemoglobinopathy Registry. Annual Report 2015/16. mdsas
National Haemoglobinopathy Registry Annual Report 2015/16 mdsas National Haemoglobinopathy Registry Annual Report (2015/16) 3 1 Introduction CHAPTER 1 This 2015/16 data update follows the same format as
More informationINTERNATIONAL FORUM PROGRAMME FOR BROADCAST (ALL TIMES BELOW ARE UK BST)
INTERNATIONAL FORUM PROGRAMME FOR BROADCAST (ALL TIMES BELOW ARE UK BST) Wednesday 22 April 2015 09:15-09:30 Welcome and opening of the Forum Fiona Godlee, Editor in Chief, The BMJ... 09:30-10:30 Keynote
More information10 5 TH TH WORKSHOP INTERNATIONAL WORKSHOP ON CO-INFECTION NEW ANTIVIRALS IN CLINICAL PRACTICE HIV & HEPATITIS AMSTERDAM, PARIS, FRANCE THE NETHERLANDS 12-13 JUNE 2014 4-5 DECEMBER 2015 MEETING PROSPECTUS
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal Review of TA215; Pazopanib for the first line treatment of advanced
More informationHepatitis B Virus therapy. Maria Buti Hospital Universitario Valle Hebron Barcelona Spain
Hepatitis B Virus therapy Maria Buti Hospital Universitario Valle Hebron Barcelona Spain Disclosures Advisor: AbbVie, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck Sharp &
More informationSafety of Treatment in Cirrhotics in the Era of New Antiviral Therapies for Hepatitis C Virus
Safety of Treatment in Cirrhotics in the Era of New Antiviral Therapies for Hepatitis C Virus JEFFREY NADELSON MD, ALAN EPSTEIN MD, THOMAS SEPE MD BOSTON UNIVERSITY SCHOOL OF MEDICINE ROGER WILLIAMS MEDICAL
More informationTreatment of chronic hepatitis delta Case report
Treatment of chronic hepatitis delta Case report George Papatheodoridis Professor in Medicine & Gastroenterology Medical School of National and Kapodistrian University of Athens, Director of Academic Department
More informationREQUEST FOR INFORMATION - HEPATITIS C TREATMENTS
10 August 2015 REQUEST FOR INFORMATION - HEPATITIS C TREATMENTS PHARMAC is seeking information from suppliers of novel direct-acting antiviral agents (DAAs) for the treatment of hepatitis C. This Request
More informationigh-sensitivity Cardiac Troponin - A Canadian Viewpoint from CIHR funded studies Friday May 30, 2014
8:50-9:00 Welcome and Introduction Juravinski Cancer Center Lecture Theatre (4 th floor) 699 Concession St. Hamilton, ON L8V 5C2 Introduction to High-Sensitivity Cardiac Troponin Current State 9:00-9:45
More informationBGCS Thursday 5 th July. Time Session Location 7:30-9:20 Registration. 8:00-9:00 INDUSTRY SPONSORED MEETING Rutherford
Thursday 5 th July Time Session Location 7:30-9:20 Registration 8:00-9:00 INDUSTRY SPONSORED MEETING Rutherford 8:00-9:00 INDUSTRY SPONSORED MEETING Wesley 9:20-9:30 Welcome and introduction Mr Tim Mould
More informationMonday 12 th November REGISTRATION opens. Tuesday 13 th November 2018 Immunocompromised Host (DAY 1)
Monday 12 th November 2018 18.00 20.00 REGISTRATION opens Tuesday 13 th November 2018 Immunocompromised Host (DAY 1) 08.30 09.30 REGISTRATION 09:30 09.45 Welcome Address and Introductions Dr Albert Mifsud,
More informationMaternal Medicine: Medical Complications in Pregnancy Joint BMFMS/RCOG Meeting
Maternal Medicine: Medical Complications in Pregnancy Joint BMFMS/RCOG Meeting 1 2 March 2018 12 credits 2 days RCOG, London Overview The course is structured to address current maternal medicine issues
More informationSession 1 - Innovation in Diagnosis and Intervention for Autism and Related Disorders
European Academy of Childhood Disability 16th Annual Meeting - EACD 2004 Satellite Meetings: 6th October 2004 Main Conference: 7th-9th October 2004 Assembly Rooms, George Street, Edinburgh, Scotland Satellite
More informationWhy to biopsy? Indications for liver biopsy in common medical liver diseases- how are they changing?
Why to biopsy? Indications for liver biopsy in common medical liver diseases- how are they changing? Stephen D Ryder Nottingham University Hospitals NHS Trust and Biomedical research Unit What are we currently
More informationTHE UNIVERSITY of EDINBURGH
THE UNIVERSITY of EDINBURGH Professor Kenneth Fearon MB ChB(Hons), MD, FRCPS (Glasgow), FRCS (Edinburgh), FRCS (England) Memorial Cancer Cachexia Symposium Royal Society of Edinburgh, George Street, Edinburgh
More informationWilhelminenspital, Vienna, Austria; 5 Queen Mary Hospital, University of London, Barts Health, London, UK; 6
Shortening overall treatment to 12 weeks of simeprevir plus PR in treatment-naïve chronic hepatitis C genotype 1 patients: assessment of baseline and Week 2 on-treatment predictors of SVR T Asselah, 1
More informationREGISTER TO ATTEND THIS FREE EVENT. brisbane diamantina health partners
BDHP Brain and Mental Health Conference Translational research in Neuroscience: Bridging the gap between basic science and clinical practice Tuesday 28 August 2018 Bancroft Auditorium QIMR Berghofer Medical
More informationThe future of liver transplantation for viral hepatitis
The future of liver transplantation for viral hepatitis François Durand Hepatology & Liver Intensive Care Hospital Beaujon, Clichy University Paris Diderot France Liver transplantation in France 2013:
More informationCRPS Network UK Conference Clinical and Scientific Advances in Complex Regional Pain Syndrome
Programme CRPS Network UK Conference Clinical and Scientific Advances in Complex Regional Pain Syndrome Thursday 10th - Friday 11th November 2016 Bailbrook House Hotel, Bath Keynote speaker: Mr Iain Stewart
More informationFatty Liver- how important is it? Jeremy F.L. Cobbold MA PhD MRCP Clinical Lecturer in Hepatology Imperial College London
Fatty Liver- how important is it? Jeremy F.L. Cobbold MA PhD MRCP Clinical Lecturer in Hepatology Imperial College London Fatty liver- how important is it? Importance in terms of: Prevalence Pathogenesis
More information30 JANUARY - 2 FEBRUARY 2018 BIR UK MRI COURSE Venue: Leeds Marriott Hotel CPD: 24 CREDITS. Platinum sponsors. Bayer have part funded this event
30 JANUARY - 2 FEBRUARY 2018 BIR UK MRI COURSE 2018 Venue: Leeds Marriott Hotel CPD: 24 CREDITS Platinum sponsors Bayer have part funded this event BIR UK MRI COURSE 2018 Venue: Leeds Marriott Hotel Date:
More informationAASLD, Boston, USA, 10 th November 2014 [oral presentation]
Effects of Sustained Virological Response on the of liver transplant, hepatocellular carcinoma, death and re-infection: meta-analysis of 129 studies in 34,563 patients with Hepatitis C infection. Andrew
More informationLYMPHOMA FORUM OF IRELAND MEETING
FORUM OF IRELAND PLENARY MEETING SPONSORED BY obbvie GILEAD SERWER Bristol-Myers Squibb janssen Forum of Ireland THE FORUM OF IRELAND PLENARY MEETING PROVIDES A PLATFORM FOR MEDICAL PROFESSIONALS THROUGHOUT
More informationManagement of Incidental Hepatitis C Virus Infection
The new england journal of medicine Clinical Decisions Interactive at nejm.org Management of Incidental Hepatitis C Virus Infection This interactive feature addresses the diagnosis or management of a clinical
More informationIs Treatment cost effective HCV and Organ Transplantation
Is Treatment cost effective HCV and Organ Transplantation Dr Kosh Agarwal Institute of Liver Studies King s College Hospital Barcelona 2016 Disclosures: BoJo Pharma support: AbbVie/Achillion/ Astellas/
More informationNHSScotland is required to consider the Scottish Health Technologies Group (SHTG) advice.
Advice Statement 010-18 July 2018 Advice Statement What is the most accurate and cost-effective direct test (ELF test, hyaluronic acid, P3NP, Fibroscan or ARFI elastography) for detecting and staging liver
More informationDAFNE Collaborative Meeting 22 June 2012, Manchester Speakers and Facilitator Biographies
DAFNE Collaborative Meeting 22 June 2012, Manchester Speakers and Facilitator Biographies Anita Beckwith Lead Diabetes Specialist Dietitian, King s College Hospital Anita Beckwith is the Lead Diabetes
More informationSharing Inspirational Experiences
Cardiff University School of Medicine Sharing Inspirational Experiences Year 2 & Y ear 5 I ntegrated Conference Heath Park Campus Cardiff 17-19 February 2015 Follow the Student Conference blog: http://blogs.cardiff.ac.uk/
More information4th UpDate on Hepatology
4th UpDate on Hepatology Course Bucharest 2017, Romania 6 th - 7 th April 2017 Bucharest - Crowne Plaza Hotel Hepatology 2017 A panoramic view" Liana GHEORGHE Course Directors Ioan SPOREA Anca TRIFAN 4
More informationHepatitis Alert: Management of Patients With HCV Who Have Achieved SVR
Hepatitis Alert: Management of Patients With HCV Who Have Achieved SVR This program is supported by educational grants from AbbVie, Gilead Sciences, and Merck About These Slides Please feel free to use,
More informationCANCER TH INTERNATIONAL CANCER CONFERENCE VENUE. 13 th 15 th May 2009 DRAFT PROGRAMME
CANCER 2009 7 TH INTERNATIONAL CANCER CONFERENCE VENUE INSTITUTE OF MOLECULAR MEDICINE, ST JAMES HOSPITAL AND TCD 13 th 15 th May 2009 DRAFT PROGRAMME WEDNESDAY 13 TH MAY 2009 St James s Hospital - Belfast
More informationLIVER CANCER: FROM BENCH TO CLINIC
Mount Sinai Liver Cancer Program Icahn Medical Institute Icahn School of Medicine at Mount Sinai Goldwurm Auditorium 1425 Madison Avenue at 98th Street New York, NY Program Director JOSEP M. LLOVET, MD
More informationInternational Symposium on Malignant Pleural Mesothelioma
International Symposium on Malignant Pleural Mesothelioma LONDON 2015 Friday 6th & Saturday 7th November 2015 Jumeirah Carlton Tower Hotel Cadogan Place Knightsbridge London SW1X 9PY United Kingdom Dear
More informationLiver transplantation for HCV and HBV in The Czech Republic. Soňa Fraňková Institute for Clinical and Experimental Medicine Prague, Czech Republic
Liver transplantation for HCV and HBV in The Czech Republic Soňa Fraňková Institute for Clinical and Experimental Medicine Prague, Czech Republic Disclosures Speaking fees: Abbvie, Gilead, MSD, Novartis
More informationUpdate in Neuromuscular Disorders Tuesday 5- Friday 8 May Clinical Neuroscience Lecture Theatre at 33 Queen Square, London WC1N 3BG PROGRAMME
Update in Neuromuscular Disorders Tuesday 5- Friday 8 May 2015 Clinical Neuroscience Lecture Theatre at 33 Queen Square, London WC1N 3BG Day 1 Tuesday 5 May PROGRAMME 10:00 10:30 Registration* and coffee
More information1 ST EUROPEAN. NASH Workshop BARCELONA, SPAIN 8-9 MARCH 2019 REQUEST FOR SUPPORT.
1 ST EUROPEAN NASH Workshop BARCELONA, SPAIN 8-9 MARCH 2019 REQUEST FOR SUPPORT NEEDS ASSESSMENT NEEDS ASSESSMENT Non-alcoholic fatty liver disease (NAFLD) is an emerging liver disease affecting 25 % of
More informationResearch Involving RaDaR: Nephrotic Syndrome - NephroS/ NURTuRE Studies. Liz Colby Project Manager, University of Bristol
Research Involving RaDaR: Nephrotic Syndrome - NephroS/ NURTuRE Studies Liz Colby Project Manager, University of Bristol What is Nephrotic Syndrome? Breakdown of the glomerular filtration barrier Massive
More informationSurgical Site Infections -
Surgical Site Infections - a 21st Century Challenge Monday 22 November 2010 Royal College of Surgeons of England, London Organised by the British Society for Antimicrobial Chemotherapy CPD Accredited Surgical
More informationTransplant Activity in the UK
Transplant Activity in the UK 2006-2007 This document has been produced by the Statistics and Audit Directorate. UK Transplant August 2007 Cover pictures: Members of Glamorgan County cricket team help
More informationThe number of patients registered on the kidney transplant list this year fell by 4% from 5,233 to 5,033
5 Kidney Activity Kidney Activity Key messages The number of patients registered on the kidney transplant list this year fell by 4% from 5,233 to 5,033 The number of deceased kidney donors increased by
More information